PCRopsis Reagent RVD with RVD Enhancer: a) 1 mL, VALIDATION USE ONLY, REF 78336001; b) 25 mL, REF 78336025; c) 100 mL, REF 78336100; Extraction-free PCR from saliva, urine, &swab specimens in transport medium, nucleic acid extraction from a variety of biological samples
Published April 5, 2023 · Recall initiated: February 21, 2023
Summary
FDA records medical device Class II recall Z-1299-2023, published April 5, 2023 and initiated February 21, 2023. Recalling firm: Entopsis , Inc.; Status: Ongoing; Reported quantity: 397 units; Lot: a) REF 78336001, Lot Numbers: 18, Exp. 05/2023; 20, Exp. 07/2023; 21, Exp. 07/2023; b) REF 78336025, Lot Numbers: 18, Exp. 05/2023; 20, Exp. 07/2023; 21, Exp. 07/2023; c) REF 78336100, Lot Numbers: 21, Exp. 07/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of misleading label statements on the product label.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Entopsis , Inc.
- Distributor
- Nationwide and Canada, UK, Portugal, England, Spain, England , Germany, Brazil, Denmark, KOR, South Korea, Colombia, Lithuania
- Lot
- a) REF 78336001, Lot Numbers: 18, Exp. 05/2023; 20, Exp. 07/2023; 21, Exp. 07/2023; b) REF 78336025, Lot Numbers: 18, Exp. 05/2023; 20, Exp. 07/2023; 21, Exp. 07/2023; c) REF 78336100, Lot Numbers: 21, Exp. 07/2023
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDATestosterone Cypionate Injection, USP, CIII, 200 mg/mL, packaged in: a) 10 mL multiple-dose vials (NDCApril 12, 2023
- FDAPCRopsis Lysis Beads, IVDD: a) 25 tubes , REF 597000; b) 25 tubes, REF 597825; c) 50 tubes, REF 597850; d) 25April 5, 2023
- FDAACL ELITE PRO-Analyzer designed specifically for clinical use in the hemostasis laboratory, for coagulationApril 5, 2023
- FDANeodent GM X 6mm Engaging Titanium Base, REF: 9007162April 5, 2023
- FDAAutomated Peritoneal Dialysis System. Used for automatic control of dialysis solution exchanges.April 5, 2023
- FDAMary s Gone Crackers Super Seed Seaweed & Black Sesame Crackers Product Item number: 10033380101 UPC: 8 53665April 5, 2023
Questions about this recall
Was PCRopsis Reagent RVD with RVD Enhancer: a) 1 mL, VALIDATION USE ONLY, REF 78336001; b) 25 mL, REF 78336025; c) 100 mL, REF 78336100; Extraction-free PCR from saliva, urine, &swab specimens in transport medium, nucleic acid extraction from a variety of biological samples recalled?
Yes. FDA published recall Z-1299-2023 on April 5, 2023. Reported hazard: Presence of misleading label statements on the product label.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail